4556 — Kainos Laboratories Cashflow Statement
0.000.00%
HealthcareAdventurousMicro CapContrarian
- ¥4bn
- ¥2bn
- ¥5bn
- 88
- 83
- 22
- 75
Annual cashflow statement for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 590 | 599 | 613 | 767 | 845 |
Depreciation | |||||
Non-Cash Items | 10.7 | 18.9 | 47.1 | 12.4 | 10.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -309 | -75.5 | -211 | -325 | -453 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 425 | 678 | 591 | 604 | 545 |
Capital Expenditures | -127 | -55.1 | -73.2 | -141 | -7.7 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 107 | 2.91 | -44 | -0.017 | -2.63 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19.9 | -52.2 | -117 | -141 | -10.3 |
Financing Cash Flow Items | 15.7 | -0.001 | -0.001 | -0.001 | -0.001 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -648 | 386 | -195 | -31.3 | -191 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -244 | 1,011 | 280 | 433 | 343 |